Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

Anthony Evnin

Director
R & D
Infinity Pharmaceuticals
United States of America

Biography

Anthony Evnin, Ph.D., lead outside director for Infinity and chair of Infinity’s Nominating and Governance Committee, has been a Partner of Venrock, a venture capital firm, since 1975. Dr. Evnin currently serves on the Board of Directors of AVEO Pharmaceuticals and Juno Therapeutics as well as on the Board of one private company, Constellation Pharmaceuticals. He is a Member of the Boards of Overseers and Managers of Memorial Sloan-Kettering Cancer Center, a Trustee of The Rockefeller University, a Trustee of The Jackson Laboratory, a Director of the New York Genome Center, a Member of the Board of Directors of the Albert and Mary Lasker Foundation, and a Trustee Emeritus of Princeton University. Dr. Evnin received an A.B. in chemistry from Princeton University and a Ph.D. in chemistry from the Massachusetts Institute of Technology. 

Research Interest

Pharmaceuticals and Juno Therapeutics as well as on the Board of one private company, Constellation Pharmaceuticals 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 13th International Conference on Biosimilars and Biologics

    November 14-15, 2018 Lisbon, Portugal

  • 14th International Conference on Generic Drugs and Biosimilars

    November 15-16, 2018 Berlin, Germany

View more
Relevant Topics